<div id="readability-page-1"><p>Quipt Home Medical (NASDAQ:QIPT - Get Free Report) is projected to release its  Q4 2025 results before the market opens on Monday, December 15th. Analysts expect Quipt Home Medical to post earnings of $0.03 per share and revenue of $87.4620 million for the quarter. Investors are encouraged to explore the company's upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Tuesday, December 16, 2025 at 4:00 PM ET.</p><div><p><span></span><span>Get <strong>Quipt Home Medical</strong> alerts:</span></p></div><h2>Quipt Home Medical Stock Performance</h2><p>QIPT stock opened at $2.43 on Monday. Quipt Home Medical has a 1 year low of $1.35 and a 1 year high of $3.27. The stock has a market capitalization of $105.56 million, a price-to-earnings ratio of -10.12 and a beta of 0.59. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.75 and a current ratio of 1.15. The stock's fifty day moving average is $2.44 and its two-hundred day moving average is $2.27. </p><h2>Institutional Trading of Quipt Home Medical</h2><p>Institutional investors have recently made changes to their positions in the stock. Kanen Wealth Management LLC increased its stake in shares of  Quipt Home Medical by 108.4% during the first quarter. Kanen Wealth Management LLC now owns 2,969,541 shares of the company's stock valued at $6,919,000 after acquiring an additional 1,544,529 shares during the period.  Vanguard Group Inc. acquired a new stake in  Quipt Home Medical in the third quarter worth approximately $4,539,000.  Franklin Resources Inc. boosted its stake in  Quipt Home Medical by 8.6% during the 3rd quarter. Franklin Resources Inc. now owns 895,398 shares of the company's stock valued at $2,337,000 after purchasing an additional 71,274 shares in the last quarter.  Arrowstreet Capital Limited Partnership boosted its stake in  Quipt Home Medical by 19.3% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 752,743 shares of the company's stock valued at $1,964,000 after purchasing an additional 121,631 shares in the last quarter.  Finally, Russell Investments Group Ltd. increased its position in shares of  Quipt Home Medical by 4.7% during the 3rd quarter. Russell Investments Group Ltd. now owns 594,590 shares of the company's stock valued at $1,552,000 after purchasing an additional 26,501 shares during the period. 42.85% of the stock is owned by institutional investors and hedge funds. </p><h2>Analyst Ratings Changes</h2><p>A number of analysts recently weighed in on the stock. Wall Street Zen raised shares of Quipt Home Medical from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Saturday, August 16th. Canaccord Genuity Group raised their price target on shares of Quipt Home Medical from $1.70 to $2.30 and gave the company a &#34;hold&#34; rating in a research note on Tuesday, August 19th. Finally, Weiss Ratings  reaffirmed a &#34;sell (e+)&#34; rating on shares of Quipt Home Medical in a report on Wednesday, October 8th. One research analyst  has rated the stock with a Buy rating, one  has assigned  a Hold rating and one  has issued  a Sell rating to the stock. According to data from MarketBeat, the stock  has an average rating of &#34;Hold&#34; and a consensus price target of $3.15.</p><p><b>Check Out Our Latest Analysis on Quipt Home Medical</b></p><h2>Quipt Home Medical Company Profile</h2> (Get Free Report)<p>Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.</p><h2>Read More</h2><ul><li>Five stocks we like better than Quipt Home Medical</li><li>Dividend Screener: How to Evaluate Dividend Stocks Before Buying</li><li>Rubrik’s Massive Rebound: Why the Next Leg Higher Could Be Fast</li><li>Low PE Growth Stocks: Unlocking Investment Opportunities</li><li>Five Below and Dollar Tree Earnings Signal a Shopper Shift</li><li>Why Are These Companies Considered Blue Chips?</li><li>Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UUlQVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UUlQVA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Quipt Home Medical Right Now?</h2><p>Before you consider Quipt Home Medical, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quipt Home Medical wasn't on the list.</p><p>While Quipt Home Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

QIPT

<p>Quipt Home Medical (NASDAQ:QIPT) will release its Q4 2025 earnings on December 15, before the market opens. Analysts expect earnings of $0.03 per share and revenue of $87.462 million. The earnings call is scheduled for December 16 at 4:00 PM ET. The stock opened at $2.43, with a market cap of $105.56 million. Institutional investors have adjusted their positions, and analysts have mixed ratings, with a consensus price target of $3.15.</p>

Quipt Home Medical (QIPT) to Release Earnings on Monday